Skip to main content

Table 3 Net transport of L-glutamate by human cancer cells and rat astrocytes.

From: Mislocalization of the exitatory amino-acid transporters (EAATs) in human astrocytoma and non-astrocytoma cancer cells: effect of the cell confluence

 

Sub-confluent cells

Confluent cells

 

control

+ PDC

+ Sulfa

control

+ PDC

+ Sulfa

AGS

+ 32 (± 15)

+ 39 (± 21)

- 9.1 (± 13)

- 74 (± 6.1)

+ 41 (± 18)

- 81.2 (± 8.4)

Caco-2

+ 36 (± 26)

+ 44 (± 18)

- 4.5 (± 9.2)

- 69.9 (± 9.6)

+ 42 (± 12)

-72.6 (± 9.6)

HeLa

+ 27 (± 12)

+ 39 (± 9.8)

- 7.8 (± 11)

- 63.2 (± 5.8)

+ 47 (± 18)

- 69.1 (± 5.2)

HOG

+ 37 (± 9.6)

+ 41 (± 12)

- 2.3 (± 3.4)

- 68.4 (± 9.4)

+ 52 (± 17)

-71.7 (± 6.8)

HT29

+ 48 (± 14)

+ 51 (± 7.5)

- 5.4 (± 9.1)

- 64.1 (± 14)

+ 49 (± 9.8)

- 69.8 (± 5.9)

SHSY5Y

+ 15 (± 9.9)

+ 34 (± 6.4)

- 13 (± 6.8)

- 74 (± 1.8)

+ 48 (± 13)

- 79.2 (± 9.4)

STTG-1

+ 52 (± 24)

+ 62 (± 13)

- 6.9 (± 3.4)

+ 69 (± 12)

+ 74 (± 9.5)

- 9.1 (± 7.9)

Astrocytes

- 79 (± 2.1)

+ 14 (± 10.9)

- 82 (± 3.4)

- 91.7 (± 2.7)

+ 21 (± 12)

- 95.6 (± 9.1)

  1. Net transport of L-glutamate was measured as explained in Materials and Methods. Results were expressed as variations of the extracellular concentration of L-glutamate after 6 h of incubation at 37°C. Initial concentration of L-glutamate in cell medium was 100 μM. Positive and negative variation values corresponded to net secretion and absorption of L-glutamate, respectively. Inhibitors used were PDC at 100 μM and sulfasalazine at 250 μM. All results were obtained from three independent experiments and were expressed as means of the variation (in μM) ± standard deviation (S.D). Values in bold are statistically different from the control values with p at least < 0.05.